Multi-Center, Randomized, Double-blinding, Positive-control, 24-Week Trial of the Efficacy and Safety of Clevudine Capsules Compared with Adefovir Dipivoxil Tablets in HBeAg Positive and Negative Chronic Hepatitis B Patients.
Phase of Trial: Phase III
Latest Information Update: 24 Apr 2016
At a glance
- Drugs Adefovir dipivoxil (Primary) ; Clevudine (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 21 May 2012 Actual end date changed from 1 Jun 2010 to 31 Dec 2010 as reported by Chinese Clinical Trial Register.
- 27 Jun 2011 New trial record